Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news


Editor’s blog

Probiotics sector forced to swallow the EU’s bitter health claims pill


By Shane Starling+

Last updated on 06-Feb-2013 at 23:15 GMT2013-02-06T23:15:53Z

Probiotic fail: Does Danone have a plan B for Activia?

On a train to Brussels to cover NutraIngredients’ Probiotech and Microbiota two-day probiotic congress, had me wondering of the sector mood now it has had its claims ripped up by the EU’s hardline health claim process.

And in my headphones? The latest Foxygen album who happen to be playing Brussels this week?

Nope – I am a health claims sad case so it is an analyst – let’s call him/her a healthy food marketing guru – absolutely ripping apart the contemporary retail strategy of Europe’s probiotic leader Danone in response to the whole sorry probiotic health claims affair.

It’s getting frostier as the train speeds north, as for EU probiotic prospects…

The guru preferred to remain anonymous for the moment but he/she had some pretty damning things to say about the French dairy giant.

Here’s how the straight lead runs on that…

Probiotic fail: Does Danone have a plan B for Activia?

Danone has failed to respond to regulatory and price-driven changes in the European yoghurt market and needs a management makeover if it is to spoon fresh life into its probiotic division, an industry analyst told us the other day.

A rampant 1990s and first half of the 2000s saw its marquee probiotic brands – Activia spoonable yoghurt and Actimel drinking yoghurt – dominate entire yoghurt markets despite hefty premiums.

Now regulatory and recessionary developments are hitting the firm hard in Europe even as global sales of Activia continue to rise and have pushed through €4.2bn.

And what is becoming clear, the analyst says, is that Danone is massively under-prepared, especially for the long-time-coming, yet industry-shocking probiotic health claim prohibition that kicked in across the EU as of December 14, 2012.

And the analyst thinks heads should roll for that, or at least fresh blood given the opportunity to rethink strategy in a division that accounts for something like a quarter of all Danone's global sales.

A change in management culture means the entrepreneurial spirit in the company has shifted to something altogether more risk-averse; something the current crisis has highlighted all too sharply.

Place for ‘Promium’?

The ban is affecting the whole sector in the European Union and beyond, but premium-priced Activia and Actimel as category leaders were always going to be the most exposed once the EU health claim assessment process rightly or wrongly stripped away its gut health and immunity marketing credentials.

“And they’ve not prepared for that,” the analyst said, noting a simultaneous rise in the popularity of various supermarket “home brands” offering the same premise – live probiotic cultures although since the ban usually known by other names like ‘bioactives’ – but at significantly reduced retail prices.

Some of those brands have surged 20-25% on home markets in the past year or two, according to market analysts.

Upper management at the firm need to be held to account for the lack of response, the observer said, as it gave the impression it has rested on its laurels for five or more years.

Danone actions

Danone did however remove its gut and immunity claims from Activia and Actimel in most European countries before the EU nutrition and health claims regulation (NHCR) ban came into play, and has also experimented with probiotic juice via brand extensions and partnerships with the likes of Chiquita and Swedish dairy, Skanemejerier, but with varying levels of success.

It has also reformulated in some markets with claim-winning nutrients like vitamins which permit it to continue its claim-making unabated. Where that is not occurring, advertising and marketing campaigns have been modified to emphasise ‘well-being’ rather than anything more specific and potentially troublesome with regulators.

So there has been some response.

But the analyst said Danone needed to implement an incremental premium price-reduction plan to have any chance of retaining market share in the new landscape, a landscape that will shrink by a couple of percentage points across Europe in the next five years according to Euromonitor.

“They deluded themselves that it would carry on growing forever,” the analyst said of Danone.

Danone was wrong on that; question is what can and will it do about it now?

It may need to look back a decade or two before it can move forward.

2 comments (Comments are now closed)


This a terribly written article! The writer hasn't made it easy to read at all.

Report abuse

Posted by Adam
09 February 2013 | 07h492013-02-09T07:49:31Z

Danone also in trouble in Italy

I note that Danone also got into trouble with the advertising authority in Italy in relation to claims made for the benefits on the bones of Danaos with added calcium.

Report abuse

Posted by Bernard O'Connor
06 February 2013 | 12h402013-02-06T12:40:47Z

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars